Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease-Reference-Cited by-同舟云学术

Novel harmine derivatives as potent acetylcholinesterase and amyloid beta aggregation dual inhibitors for management of Alzheimer’s disease

Author:

Du Hongtao¹²^ORCID,Song Jinzhi³,Ma Fang²⁴,Gao Hongxin⁵,Zhao Xinyan⁶,Mao Renjun¹³,He Xiaolong¹,Yan Yan¹²

Affiliation:

1. School of Life Sciences, Yan’an University, Yan'an, China

2. Shaanxi Qi Yuan Kang Bo Biotechnology Co. LTD, Tongchuan Shaanxi, China

3. Shaanxi Horticultural Technology workstation, Xi’an Shaanxi, China

4. Northwest Agriculture & Forestry University, Xianyang, China

5. School of Graduate Studies, Lingnan University, Hong Kong, China

6. Second School of Clinical Medicine, Shaanxi University of Chinese Medicine, Xianyang Shaanxi, China

Funder

Program for Natural Science Foundation of China

Qin Chuan Yuan cited the high-level innovation and entrepreneurship talent program of Shaanxi

Doctoral Research Initiation Project of Yan’an University

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,General Medicine

Link

Reference37 articles.

3. Alzheimer’s Disease International. World Alzheimer Report. 2016. https://www.alz.co.uk/research/WorldAlzheimerReport2016.pdf.

5. Approval of aducanumab for Alzheimer’s disease in the United States: the surrender of science;Dal–Re R.;Rev Neurologia,2021

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献